Imexpharm

Imexpharm Free Cash Flow

The Free Cash Flow (FCF) of Imexpharm (IMP.VN) as of Oct 26, 2026 is 27.29 B VND. In the previous year, Free Cash Flow (FCF) was 119.50 B VND — a change of -77.16% (lower).

Free Cash Flow

27.29 BVND

YoY

-77.16%

Last updated:

Free Cash Flow (FCF) of Imexpharm is 2025 27.29 B VND. Free Cash Flow (FCF) of Imexpharm was 2024 119.50 B VND. It decreases by -77.16% lower compared to the previous year.

The Imexpharm Free Cash Flow history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Free Cash Flow
Date
Free Cash Flow
Jan 1, 2018
-140.35 B VND
Jan 1, 2019
-64.53 B VND
Jan 1, 2020
-16.53 B VND
Jan 1, 2021
182.02 B VND
Jan 1, 2022
279.25 B VND
Jan 1, 2023
-103.57 B VND
Jan 1, 2024
119.50 B VND
Jan 1, 2025
27.29 B VND
The Imexpharm Free Cash Flow history
YEARFree Cash FlowYoY
27.29 BVND-77.16%
119.50 BVND-215.38%
-103.57 BVND-137.09%
279.25 BVND+53.41%
182.02 BVND-1,201.09%
-16.53 BVND-74.38%
-64.53 BVND-54.02%
-140.35 BVND-20.82%
-177.24 BVND+820.58%
-19.25 BVND-37.06%
-30.59 BVND+93.10%
-15.84 BVND—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Imexpharm Stock analysis

What does Imexpharm do? Imexpharm Corp manufactures and trades pharmaceuticals, medicinal chemicals, and botanical products, including antiseptics, traditional medicine, medical equipment, cosmetics, and supplemental food and drinks. The company provides packaging and warehousing services specifically for pharmaceutical storage. It also cultivates medicinal herbs. Imexpharm Corp serves the pharmaceutical industry and healthcare sector through its manufacturing, import, export, and trade operations, targeting businesses requiring medicinal products and services. The company's revenue streams include the sale of manufactured pharmaceuticals, imported and exported goods, and services such as packaging and warehousing. Its customers are businesses in the healthcare sector, including distributors and retailers of pharmaceuticals, medical equipment, and related products. The firm's operations span manufacturing, import, export, and trade, with additional services supporting the pharmaceutical supply chain. Imexpharm Corp's product portfolio covers a wide range of medicinal and health-related items, from antiseptics to supplemental food and drinks. The company's involvement in medicinal herb cultivation supports its production of traditional medicine and herbal-based products. This vertical integration enhances its ability to supply comprehensive solutions to healthcare businesses. Imexpharm is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Imexpharm stock

Free Cash Flow (FCF) of Imexpharm is 27.29 B VND in 2025.

Free Cash Flow (FCF) of Imexpharm changed from 119.50 B VND to 27.29 B VND, representing a -77.16% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow (FCF) Imexpharm since 2006 – with annual values, charts, and detailed analysis.

Free Cash Flow is the cash available after capital expenditures. It represents the cash a company can use for dividends, debt reduction, or reinvestment.

FCF = Operating Cash Flow - Capital Expenditures

Free Cash Flow (FCF)'s VND is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Free Cash Flow (FCF)'s Imexpharm historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Imexpharm

All Key Metrics — Imexpharm